Medical Device and IVD Companies QSR Audits Services

FDA Quality System Regulation

For medical device and In Vitro Diagnostic (IVD) manufacturers seeking to enter or maintain their presence in the United States market, compliance with the FDA Quality System Regulation (QSR) is a non-negotiable legal requirement. Codified under 21 CFR Part 820, the QSR outlines the essential requirements for the design, manufacture, packaging, labeling, storage, and servicing of finished devices. Unlike some international standards that emphasize voluntary certification, the QSR is a federal regulation enforced through rigorous FDA inspections.

As the FDA continues its transition toward the Quality Management System Regulation (QMSR)—which aims to harmonize 21 CFR Part 820 with the international ISO 13485:2016 standard—manufacturers face a critical period of adaptation. A proactive auditing strategy is essential to identify potential non-conformities before a formal FDA investigator arrives at your facility. Failure to demonstrate a robust quality system during an inspection can lead to the issuance of a Form 483, Warning Letters, or even consent decrees that severely disrupt business operations.

Critical Focus Areas of QSR Compliance Audits

A comprehensive QSR audit evaluates the effectiveness of a manufacturer's quality management system (QMS) in ensuring device safety and efficacy. Our auditing methodology focuses on the core subsystems that are most frequently scrutinized by the FDA.

Management Controls and Responsibility

The FDA expects senior management to take an active role in the quality system. Audits assess whether management has established a clear quality policy, allocated sufficient resources, and conducted regular management reviews. A failure in management controls is often viewed by investigators as a systemic weakness that impacts all other areas of the QMS.

Design controls and risk management

One of the most common areas for FDA 483 observations is the design control process. Audits verify that manufacturers have established adequate procedures for design inputs, outputs, verification, and validation. Furthermore, the integration of risk management throughout the entire design and production process is evaluated to ensure that all potential hazards are identified and mitigated.

Corrective and Preventive Action (CAPA)

The CAPA system is frequently considered the "heart" of the quality system by the FDA. Audits scrutinize how companies identify quality problems, investigate root causes, and implement effective corrective actions to prevent recurrence. A stagnant or ineffective CAPA system is a major red flag that indicates a lack of continuous improvement.

Strategic Importance of Third Party Auditing

Engaging in independent, third-party audits provides an objective perspective that internal audits may lack. These assessments are designed to simulate the intensity and focus of an actual FDA inspection, utilizing the Quality System Inspection Technique (QSIT). By identifying "blind spots" in documentation or process implementation, manufacturers can rectify issues in a controlled environment.

Furthermore, as the industry prepares for the full implementation of the QMSR by early 2026, third-party audits serve as a critical gap analysis tool. They ensure that the transition from the legacy QSR to the new harmonized framework is seamless, minimizing the risk of regulatory friction. Maintaining a high level of audit readiness not only protects a company's reputation but also ensures that life-saving medical technologies remain available to patients without interruption.

Proregulations' QSR Audit and Compliance Services

Our standardized service process facilitates the efficient evaluation of your quality system to ensure it meets the rigorous expectations of the FDA. We offer a comprehensive suite of solutions to manage your audit readiness lifecycle.

• Mock FDA and QSIT audits
  We conduct comprehensive simulated inspections using the FDA's own QSIT methodology to evaluate your readiness and identify high-risk non-conformities.
• FDA 483 and Warning Letter remediation
  Our experts provide technical support in drafting responses to FDA observations and assist in implementing sustainable corrective action plans to resolve compliance issues.
• QMSR transition and gap analysis
  We assess your current QMS against the new QMSR requirements (incorporating ISO 13485:2016) to provide a clear roadmap for regulatory alignment.
• Supplier and internal audit programs
  We provide independent auditing services for your critical suppliers and internal departments to ensure end-to-end quality system integrity.
• QSR staff training and coaching
  We provide targeted training for quality teams and front-room/back-room personnel on how to interact with FDA investigators and manage the audit process.
• Design history file and technical file reviews
  We perform deep-dive reviews of your DHF and technical documentation to ensure they meet the specific evidence requirements for safety and performance.

If you are interested in our QSR audit services and wish to strengthen your compliance posture for the US market, please feel free to contact us.